An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.



Project measures / variables set:   Wiltshire3   SLC6A2

ID, description, units MPD:38179   SLC6A2   cerebral cortex SLC6A2 (NET), relative fluorescence intensity    
fluoxetine study
Measures
• control    • fluoxetine    • change index
Data set, strains Wiltshire3   inbred   30 strains     sex: m     age: 10-11wks
Procedure biomarker quantification
Comparisoncontrol group vs. treated group
Availability note:Individual animal data were not submitted. Some functionality not available.
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Wiltshire3 - cerebral cortex SLC6A2 (NET), relative fluorescence intensity




  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested		SexAge
Wiltshire3 38179 biomarker quantification fluoxetine cerebral cortex SLC6A2 (NET), relative fluorescence intensity   control  SLC6A2_cont inbred 30 m 10-11wks
Wiltshire3 38180 biomarker quantification fluoxetine cerebral cortex SLC6A2 (NET), relative fluorescence intensity   fluoxetine  SLC6A2_fluox inbred 30 m 10-11wks
Wiltshire3 38181 biomarker quantification fluoxetine cerebral cortex SLC6A2 (NET), relative fluorescence intensity   change index  SLC6A2_index inbred 30 m 10-11wks (supplemental /
  summary measure)



  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder